We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

LumiQuick Diagnostics

LumiQuick Diagnostics Inc. develops, manufactures and markets high quality point of care tests and other immunoassay ... read more Featured Products: More products

Download Mobile App




Lumiquick Acquires Aoxre to Expand Global IVD and Research Capabilities

By LabMedica International staff writers
Posted on 29 Sep 2025

Oxidative stress has been linked to cellular damage involving proteins, DNA, and lipids, and it plays a role in conditions such as cardiovascular disorders, diabetes, neurodegenerative diseases (Alzheimer’s and Parkinson’s), cancer, and chronic infections. More...

Detecting and monitoring oxidative stress biomarkers is essential for both clinical diagnostics and research, yet current tools remain fragmented and limited in reach. To address this, a major acquisition is set to expand global access to advanced diagnostic solutions and research tools.

Lumiquick Diagnostics (Santa Clara, CA, USA), a developer and manufacturer of in vitro diagnostic (IVD) tests, has acquired AOXRE LLC (Burlingame, CA, USA), which is recognized for its innovative OxisResearch product line. At the heart of the OxisResearch product line are the Bioxytech assay kits targeting oxidative and nitrosative stress biomarkers.

With this acquisition, customers can expect the full product line of oxidative stress markers and companion diagnostic assays, including Cellular Damage Monitoring, REDOX balance assessment, ELISA, and rapid test of various biological markers that are associated with the oxidation status of the human body.

This strategic acquisition marks a significant milestone for Lumiquick as it continues to expand its global footprint and product portfolio in the IVD & research industries. AOXRE’s expertise, technology, and customer relationships will be fully integrated into Lumiquick’s operations, strengthening the company’s position as a comprehensive provider of high-quality diagnostic and research tools.

“We are thrilled to welcome AOXRE into the Lumiquick Diagnostics family,” said Charles Yu, President of Lumiquick Diagnostics. “The addition of the AOXRE product line will strengthen LumiQuick’s ability to support both the clinical and research communities.”

Related Links:
Lumiquick Diagnostics
AOXRE LLC


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new method can contribute to earlier detection of cirrhosis and liver cancer (Photo courtesy of 123RF)

Simple Test Predicts Risk of Severe Liver Disease

Severe liver diseases such as cirrhosis and liver cancer are becoming increasingly common and often carry a poor prognosis when detected late. Current screening tools are limited in their ability to identify... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.